News
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Novo Nordisk A/S (NYSE:NVO) is among the best bear market stocks to buy according to analysts. Novo Nordisk A/S (NYSE:NVO) has reclaimed its crown as Europe’s most valuable publicly traded company, ...
Alibaba Group Holding Limited (NYSE:BABA) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now. Alibaba Group ...
This, and the fact that we made substantial additional purchases on 14 April 2025, has secured Oracle first place in our share portfolio. After a mixed previous quarter, US software group Oracle now ...
Novo Nordisk A/S shares are staging a comeback after a tumultuous year for the maker of Ozempic and Wegovy. The stock is up ...
We extend our thanks to our partner SAP for their support and active participation in TechCrunch Sessions: AI, held on June 5, 2025, at UC Berkeley. Attendees gathered in the Pauley East Breakout Room ...
The most notable example of this trend is Germany's DAX index, which comprises the 40 largest publicly listed companies on the Frankfurt Stock Exchange. Since the end of the bear market in October ...
According to JPMorgan, the software sector remains a critical one for US venture investors, capturing ~60% of venture dollars ...
In a report released today, Andreas Wolf from Warburg Research maintained a Buy rating on SAP SE (0NW4 – Research Report), with a price target of €295.00. The company’s shar ...
Boasting a market value of $350 billion as of the end of May, SAP outpaced a struggling Novo Nordisk and a stunted luxury ...
German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results